• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    10.04 Down 0.28(2.76%) Apr 17, 4:00PM EDT
    |After Hours : 10.04 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
    Add to Portfolio
    Prev Close:10.33
    Open:10.17
    Bid:9.92 x 300
    Ask:11.32 x 1000
    1y Target Est:20.80
    Beta:3.56
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:9.85 - 10.45
    52wk Range:6.33 - 14.20
    Volume:1,058,402
    Avg Vol (3m):959,900
    Market Cap:609.84M
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INO

    Comparison

    Symbol% ChgMkt Cap
    INODown 2.76%609.84M
    AZNDown 0.99%90.09B
    PFEDown 0.43%214.76B
    SNYDown 0.88%135.14B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):59.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.73
    Quarterly EPS Est (Mar-15) :-0.11
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback